KORU Medical Systems, Inc. (KRMD): Cost of Revenue

Annual figures by period end, from SEC filings.

$15.52M
Year ended 2025-12-31
$16.95M
Trailing 12 months to 2026-06-30
+7.4%
3-year compound annual growth
+10.9%
5-year compound annual growth
2018-12-31: $6.54M2019-12-31: $8.31M2020-12-31: $9.24M2021-12-31: $9.72M2022-12-31: $12.53M2023-12-31: $11.81M2024-12-31: $12.31M2025-12-31: $15.52M$15.52M
2018-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$15.52M+26.1%2026-03-12, From 2025-01-01
2024-12-31$12.31M+4.3%2026-03-12, From 2024-01-01
2023-12-31$11.81M-5.7%2025-03-12, From 2023-01-01
2022-12-31$12.53M+28.9%2024-03-13, From 2022-01-01
2021-12-31$9.72M+5.2%2023-03-08, From 2021-01-01
2020-12-31$9.24M+11.2%2022-03-02, From 2020-01-01
2019-12-31$8.31M+27.0%2021-03-23, From 2019-01-01
2018-12-31$6.54Mn/a2020-03-04, From 2018-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
KORU Medical Systems, Inc. (KRMD)2025-12-31$15.52M+26.1%
SS Innovations International, Inc. (SSII)2025-12-31$22.94M+88.1%
Interpace Biosciences, Inc. (IDXG)2025-12-31$14.60M-14.1%
Utah Medical Products Inc (UTMD)2025-12-31$16.52M-1.4%
SANUWAVE Health, Inc. (SNWV)2025-12-31$10.08M+24.7%
Retractable Technologies Inc (RVP)2025-12-31$38.22M+12.2%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$6.96M+69.8%
Cytosorbents Corp (CTSO)2025-12-31$10.57M-1.3%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$14.28M+16.4%

Compare KRMD, SSII, IDXG, UTMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗